Description:

Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Keywords:
Versions (4) ▾
  1. 10/5/17
  2. 2/22/18
  3. 2/22/18
  4. 2/22/18
Copyright Holder:
gsk
Uploaded on:

February 22, 2018

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Ropinirole Case Report Form GSK RRL100013

STATUS OF TREATMENT BLIND

Status
Was the treatment blind broken during the study?
Reason blind broken
PGx-PHARMACOGENETIC RESEARCH INSTRUCTIONS
PGx-PHARMACOGENETIC RESEARCH
CONSENT FOR PGx-PHARMACOGENETIC RESEARCH
Informed consent if no
Has a blood sample been collected for PGx-pharmacogenetic research?
Has subject withdrawn consent for PGx-Pharmacogenetic research?
BLOOD SAMPLE DESTRUCTION
If Yes: BLOOD SAMPLE DESTRUCTION
UNITS